AHMED NADIM 4
4 · Cullinan Therapeutics, Inc. · Filed Dec 27, 2024
Insider Transaction Report
Form 4
AHMED NADIM
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-12-24$11.87/sh−8,400$99,708→ 263,150 total
Footnotes (1)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.